The GCTSEQ-2000 gene sequencer developed by Zhenyue Biotechnology Jiangsu, located in the Taizhou Medical High-tech Zone, Taizhou city, East China's Jiangsu province, recently received a medical device registration certificate from the National Medical Products Administration.
This marks the company's one-stop and in-hospital solution for medical institutions has covered the entire process. That's from gene sequencing library preparation equipment to gene sequencing reagents – and then to gene sequencing equipment and gene testing data management software.
The gene sequencing product has adopted DNBSEQTM technology, or DNA nanosphere sequencing technology and a new slide system, which can flexibly support multiple sequencing modes.
Optimized optical and biochemicals systems have also been adopted, providing users with a more streamlined and smooth sequencing experience.
As a leading company in China's tumor molecular diagnosis and testing industry, Zhenyue has a complete independent research and development technology platform.
This provides patients with comprehensive molecular testing services covering early diagnosis, medication guidance and prognosis monitoring.